1. Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases
    Lila Carniglia et al, 2017, Mediators of Inflammation CrossRef
  2. The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins
    Mark S. Moehle et al, 2015, Hum. Mol. Genet. CrossRef
  3. Peripheral immune tolerance alleviates the intracranial lipopolysaccharide injection-induced neuroinflammation and protects the dopaminergic neurons from neuroinflammation-related neurotoxicity
    Yang Liu et al, 2017, J Neuroinflammation CrossRef
  4. Neurochemical characterization of nerve fibers in the porcine gallbladder wall under physiological conditions and after the administration of Salmonella enteritidis lipopolysaccharides (LPS).
    Krystyna Makowska et al, 2018, Toxicol Res (Camb) CrossRef
  5. Modulation of the main porcine enteric neuropeptides by a single low-dose of lipopolysaccharide (LPS) Salmonella Enteritidis
    Anita Mikołajczyk et al, 2017, Gut Pathog CrossRef
  6. Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease
    Ren-Hong Du et al, 2018, Cell Death Dis CrossRef
  7. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo.
    Eugene Bok et al, 2018, Exp Mol Med CrossRef
  8. The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson’s Disease
    Yong-Fei Zhao et al, 2018, Aging and disease CrossRef
  9. The Role of Lipids in Parkinson’s Disease
    Helena Xicoy et al, 2019, Cells CrossRef
  10. Reduced expression of somatostatin in GABAergic interneurons derived from induced pluripotent stem cells of patients with parkin mutations.
    Chizuru Iwasawa et al, 2019, Mol Brain CrossRef
  11. Subclinical Lipopolysaccharide from Salmonella Enteritidis Induces Dysregulation of Bioactive Substances from Selected Brain Sections and Glands of Neuroendocrine Axes
    Anita Mikołajczyk et al, 2019, Toxins CrossRef
  12. Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice
    Ashok Jangra et al, 2016, Inflammation CrossRef
  13. Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson’s Disease
    Yan-Hua Li et al, 2017, Mol Neurobiol CrossRef
  14. Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide
    Huan He et al, 2016, BMC Complement Altern Med CrossRef
  15. Antidepressant-like effect of pramipexole in an inflammatory model of depression
    Vicente Lieberknecht et al, 2017, Behavioural Brain Research CrossRef
  16. The effects of hydro-ethanolic extract of Capparis spinosa (C. spinosa) on lipopolysaccharide (LPS)-induced inflammation and cognitive impairment: Evidence from in vivo and in vitro studies
    Vafa Baradaran Rahimi et al, 2020, Journal of Ethnopharmacology CrossRef
  17. Tualang honey and its methanolic fraction ameliorate lipopolysaccharide-induced oxidative stress, amyloid deposition and neuronal loss of the rat hippocampus
    Wan Muhammad Hilmi Wan Yaacob et al, 2020, ADV TRADIT MED (ADTM) CrossRef
  18. HOTAIR Accelerates Dyskinesia in a MPTP-Lesioned Mouse Model of PD via SSTR1 Methylation-Mediated ERK1/2 Axis
    Lijun Cai et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
  19. Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma
    Yi Zhang et al, 2021, Experimental Eye Research CrossRef
  20. Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-κB pathway
    Sung Eun Kim et al, 2021, PLoS ONE CrossRef
  21. Nuclear factor‐kappa B (NF‐κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration
    Mahsa Dolatshahi et al, 2021, Eur J Neurosci CrossRef
  22. PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells
    Jocelyn Karunia et al, 2021, IJMS CrossRef
  23. Protective Role of Capsaicin in Neurological Disorders: An Overview
    Sakshi Tyagi et al, 2022, Neurochem Res CrossRef
  24. Novel Somatostatin Receptor-4 Agonist SM-I-26 Mitigates Lipopolysaccharide-Induced Inflammatory Gene Expression in Microglia
    Ashok Silwal et al, 2022, Neurochem Res CrossRef
  25. Protective effects of endotoxin tolerance on peripheral lipopolysaccharide-induced neuroinflammation and dopaminergic neuronal injury
    Liyan Yao et al, 2022, Immunopharmacology and Immunotoxicology CrossRef
  26. Perinatal exposure to synergistic multiple stressors leads to cellular and behavioral deficits mimicking Schizophrenia-like pathology
    Tiyasha Sarkar et al, 2022 CrossRef
  27. Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective.
    Simona Bungau, 0 CrossRef
  28. Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
    Valerio Chiurchiù et al, 2022, IJMS CrossRef
  29. Regional heterogeneity in mitochondrial function underlies region specific vulnerability in human brain ageing: Implications for neurodegeneration
    Yarlagadda Anusha-Kiran et al, 2022, Free Radical Biology and Medicine CrossRef
  30. Role of Microglial Metabolic Reprogramming in Parkinson's Disease
    Zheng-ping Huang et al, 2023, Biochemical Pharmacology CrossRef
  31. Deciphering the molecular pathways underlying dopaminergic neuronal damage in Parkinson's disease associated with SARS-CoV-2 infection
    Qiuhan Xu et al, 2024, Computers in Biology and Medicine CrossRef
  32. Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting
    Karin E. Sandoval et al, 2024, Pharmacol Rev CrossRef
  33. Peptide discovery across the spectrum of neuroinflammation; microglia and astrocyte phenotypical targeting, mediation, and mechanistic understanding
    Benjamin A. Benita et al, 2024, Front. Mol. Neurosci. CrossRef